Informationen:
Fehler:
ID
16466
Beschreibung
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00523640
Link
https://clinicaltrials.gov/show/NCT00523640
Stichworte
Versionen (1)
- 17.07.16 17.07.16 -
Hochgeladen am
17. Juli 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Carcinoma, Renal Cell NCT00523640
Eligibility Carcinoma, Renal Cell NCT00523640
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Carcinoma, Renal Cell NCT00523640
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
metastatic clear cell renal cell carcinoma
Item
histologically or cytologically confirmed metastatic clear cell renal cell cancer
boolean
C0279702 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
Measurable disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Age
Item
age 18 or older
boolean
C0001779 (UMLS CUI [1])
ECOG
Item
ecog performance status of 0 - 1
boolean
C1520224 (UMLS CUI [1])
Blood pressure
Item
blood pressure less than 140/90 on 2 separate occasions not more than 6 weeks prior to enrollment and not less than 24 hours apart
boolean
C0005823 (UMLS CUI [1])
organ function
Item
normal organ function
boolean
C0678852 (UMLS CUI [1])
Contraception
Item
women of child-bearing potential and men must agree to use adequate contraception
boolean
C0700589 (UMLS CUI [1])
Written informed consent
Item
ability to understand and the willingness to sign a written informed consent document and to follow all required study procedures
boolean
C0021430 (UMLS CUI [1])
prior chemotherapy or radiotherapy
Item
patients who have had chemotherapy or radiotherapy within 4 weeks prior to entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier
boolean
C0279025 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
prior treatment with pyrimidine analogs or vegf binding agents
Item
patients may not have had prior treatment with pyrimidine analogs or vegf binding agents
boolean
C0280039 (UMLS CUI [1])
C0596087 (UMLS CUI [2])
C0596087 (UMLS CUI [2])
Other investigational or therapeutic agents
Item
patients may not be receiving any other investigational or therapeutic agents
boolean
C0013230 (UMLS CUI [1])
C1611640 (UMLS CUI [2])
C1611640 (UMLS CUI [2])
Anticoagulants
Item
patients may not be receiving therapeutic anticoagulation with warfarin, its congeners, heparin, low molecular weight heparinoids, specific thrombin inhibitors, or other similar agents patients receiving low dose coumadin (1 mg daily) for central line patency are eligible
boolean
C0003280 (UMLS CUI [1])
major surgical procedure, open biopsy, or significant traumatic injury
Item
major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to treatment start, or anticipation of need for major surgical procedure during the course of the study fine needle aspirations or core biopsies within 7 days prior to treatment start are acceptable
boolean
C0543467 (UMLS CUI [1])
C0184922 (UMLS CUI [2])
C3263723 (UMLS CUI [3])
C0184922 (UMLS CUI [2])
C3263723 (UMLS CUI [3])
Serious, non healing wound, ulcer, or bone fracture
Item
serious, non healing wound, ulcer, or bone fracture
boolean
C0750433 (UMLS CUI [1])
C0041582 (UMLS CUI [2])
C0016658 (UMLS CUI [3])
C0041582 (UMLS CUI [2])
C0016658 (UMLS CUI [3])
Bleeding diathesis or coagulopathy
Item
evidence of bleeding diathesis or coagulopathy
boolean
C0005779 (UMLS CUI [1])
Brain metastases
Item
patients with known brain metastases
boolean
C0220650 (UMLS CUI [1])
uncontrolled intercurrent illness
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1])
Pregnancy
Item
pregnant women
boolean
C0032961 (UMLS CUI [1])
Anti-retroviral therapy
Item
hiv-positive patients receiving combination anti-retroviral therapy are excluded from the study
boolean
C1963724 (UMLS CUI [1])